Biotronik
Biotronik settles kickbacks case for $5m
Federal prosecutors yesterday said Biotronik agreed to pony up $4.9 million, but admitted no wrongdoing, to settle allegations that it ran a kickbacks scheme to induce physicians to use its cardiac rhythm management devices.
Biotronik study: Remote heart monitoring helps save lives
Home-based heart monitoring could help save lives while reducing the cost of follow-up care for patients with heart failure, according to a new study.
Conor MedSystems can’t slip $100 million breach of contract lawsuit | Medtech legal news for the week of May 26, 2014
Biotronik touts major expansion of MRI-friendly implant studies
Oregon-based heart devices maker Biotronik touted FDA approval to expand its ProMRI clinical trials, permitting the company to enroll patients with implantable cardioverter defibrillators for full-body MRI scanning.
Press Release: FDA Approves Expansion of BIOTRONIK ProMRI ICD Trial to Include Full-Body Scans and DX Technology
J&J’s Conor MedSystems can’t slip $100M Biotronik lawsuit
Johnson & Johnson (NYSE:JNJ) subsidiary Conor MedSystems can’t slip a $100 million breach of contract lawsuit filed by former European distribution partner Biotronik, a New York state appeals court ruled last week.
Battery wars at HRS2014: And the winner is?
A string of presentations and poster sessions during this week’s Heart Rhythm conference pitted device makers against each other in the battle for battery superiority.
HRS2014: Medtronic cardiac rhythm implants fail 1st in head-to-head studies of longevity, researchers say
FDA says Biotronik’s pacemakers are MRI-friendly | MassDevice.com On Call
MASSDEVICE ON CALL — Oregon-based Biotronik said it won FDA approval for its Entovis pacemaker system with ProMRI technology, the latest in MRI-friendly pacing systems approved for the U.S.
The Entovis is the 1st FDA-approved MRI-friendly pacemaker with both single- and dual-chamber pacing options, Biotronik said. The company added that it’s the 1st worldwide to couple MRI-safe pacing with current-generation leads.
Biotronik wins CE Mark for drug releasing balloon
Biotronik won European regulatory approval for its Passeo-18 Lux drug releasing balloon and the company is beginning commercial efforts in all CE Mark countries.